Why Good Science Isn’t Enough to Build a Biotech | Vera Therapeutics' Marshall Fordyce
What does it take to turn promising science into a biotech company that gets medicines to patients? Dr Marshall Fordyce, Founder and CEO of Vera Therapeutics, joins Max Brennan on The BioHub to discuss building a biotech, funding drug development and keeping patients at the centre of business decisions. From treating patients with HIV to developing medicines at Gilead and founding Vera, Marshall shares the experiences that shaped his approach to leadership. We explore why scientific evidence, the right people and financial discipline all matter—and why “no cash, no company” is a reality bio…